- Home
- AGEN vs STG Comparison
AGEN vs STG Comparison
Compare AGEN & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- STG
- Stock Information
- Founded
- AGEN 1994
- STG 2003
- Country
- AGEN United States
- STG China
- Employees
- AGEN N/A
- STG N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- STG Other Consumer Services
- Sector
- AGEN Health Care
- STG Real Estate
- Exchange
- AGEN Nasdaq
- STG Nasdaq
- Market Cap
- AGEN 96.2M
- STG 91.7M
- IPO Year
- AGEN 2000
- STG 2018
- Fundamental
- Price
- AGEN $2.86
- STG $6.98
- Analyst Decision
- AGEN Buy
- STG
- Analyst Count
- AGEN 3
- STG 0
- Target Price
- AGEN $9.33
- STG N/A
- AVG Volume (30 Days)
- AGEN 576.6K
- STG 5.8K
- Earning Date
- AGEN 11-12-2024
- STG 11-22-2024
- Dividend Yield
- AGEN N/A
- STG N/A
- EPS Growth
- AGEN N/A
- STG N/A
- EPS
- AGEN N/A
- STG 4.83
- Revenue
- AGEN $160,427,000.00
- STG $286,479,516.00
- Revenue This Year
- AGEN N/A
- STG N/A
- Revenue Next Year
- AGEN $0.04
- STG N/A
- P/E Ratio
- AGEN N/A
- STG $1.43
- Revenue Growth
- AGEN 59.00
- STG N/A
- 52 Week Low
- AGEN $2.50
- STG $4.25
- 52 Week High
- AGEN $19.69
- STG $12.55
- Technical
- Relative Strength Index (RSI)
- AGEN 28.17
- STG 52.54
- Support Level
- AGEN $2.50
- STG $6.60
- Resistance Level
- AGEN $2.89
- STG $7.12
- Average True Range (ATR)
- AGEN 0.29
- STG 0.24
- MACD
- AGEN -0.07
- STG 0.03
- Stochastic Oscillator
- AGEN 18.75
- STG 100.00
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.